What is IVX Health?
IVX Health is a Brentwood, Tennessee-based healthcare provider dedicated to the treatment of complex chronic illnesses, including Crohn's Disease and Lupus. The company operates at the intersection of clinical excellence and patient convenience, offering specialized infusion and injection services in a community-based setting. By focusing on high-acuity conditions that require ongoing management, IVX Health addresses a critical gap in the healthcare ecosystem, providing a more accessible and cost-effective alternative to traditional hospital-based infusion centers. Their market position is defined by a commitment to improving patient outcomes through specialized care delivery and a scalable operational framework that supports rapid expansion across regional markets.
How much funding has IVX Health raised?
IVX Health has raised a total of $149.5M across 4 funding rounds:
Private Equity
$13.5M
Series B
$13.5M
Series C
$22.5M
Series F
$100M
Private Equity (2017): $13.5M, investors not publicly disclosed
Series B (2017): $13.5M led by McKesson Ventures and Health Velocity Capital
Series C (2019): $22.5M supported by McKesson Ventures, CrimsoNox Capital, Nueterra Capital, and Health Velocity Capital
Series F (2021): $100M featuring Great Hill Partners
Key Investors in IVX Health
Great Hill Partners
Great Hill Partners is a Boston-based private equity firm that has raised over many billions in commitments since inception to finance the acquisition, recapitalisation, or expansion of growth companies in the communications, financial technology, healthcare, information services, internet, media, retail, consumer, and software industries.
Health Velocity Capital
Health Velocity Capital is an investment firm that focuses exclusively on innovative healthcare software and services businesses. The company aims to foster a more affordable, sustainable, and consumer-friendly future in healthcare.
Nueterra Capital
Nueterra Capital focuses on investing in the integration of healthcare and technology, aiming to empower the next generation of start-ups by providing support and resources to innovative businesses in the healthcare sector.
What's next for IVX Health?
With the infusion of this latest capital, IVX Health is well-positioned to accelerate its strategic roadmap, which likely includes the expansion of its clinical network and the integration of advanced patient management technologies. The company's focus on chronic condition management provides a stable foundation for long-term growth, particularly as healthcare systems prioritize value-based care models. Future initiatives will likely center on enhancing operational efficiencies, deepening partnerships with health systems, and scaling its unique care delivery model to reach a broader patient demographic. As the firm moves beyond its current growth stage, the emphasis will shift toward sustaining clinical quality while aggressively capturing market share in the outpatient infusion sector.
See full IVX Health company page
